| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |